Literature DB >> 25122018

The tobacco industry, researchers, and ethical access to UK Biobank: using the public interest and public good.

Benjamin James Capps1, Yvette van der Eijk.   

Abstract

We have asked whether the strategic purpose of the tobacco industry is something that a public resource, such as UK Biobank, should support. Tobacco industry health research has been known to work irreconcilably with the purposes of such institutions, which can be surmised as for the public good and defined to improve the provision, diagnosis, and treatment of illness and the promotion of health throughout society. We have isolated possible conflicts of interest that underlie vested research agendas of the tobacco industry and that may extend to tobacco industry-funded researchers. With respect to research, we find that the tobacco industry is entirely at odds with the purposes of public biobanking.

Entities:  

Mesh:

Year:  2014        PMID: 25122018      PMCID: PMC4167123          DOI: 10.2105/AJPH.2014.302138

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  18 in total

1.  The ethics of research using biobanks: reason to question the importance attributed to informed consent.

Authors:  Klaus Hoeyer; Bert-Ove Olofsson; Tom Mjörndal; Niels Lynöe
Journal:  Arch Intern Med       Date:  2005-01-10

2.  Partnership in U.K. Biobank: a third way for genomic property?

Authors:  David E Winickoff
Journal:  J Law Med Ethics       Date:  2007       Impact factor: 1.718

3.  CYP2D6 genotypes in cigarette smokers and non-tobacco users.

Authors:  S Cholerton; C Boustead; H Taber; A Arpanahi; J R Idle
Journal:  Pharmacogenetics       Date:  1996-06

4.  Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County.

Authors:  S J London; A K Daly; J Cooper; C L Carpenter; W C Navidi; L Ding; J R Idle
Journal:  Pharmacogenetics       Date:  1996-04

5.  Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California.

Authors:  S J London; A K Daly; J B Leathart; W C Navidi; J R Idle
Journal:  Pharmacogenetics       Date:  1996-12

6.  Familial lung cancer--correcting an error in calculation.

Authors:  W L Ooi; R C Elston; V W Chen; J E Bailey-Wilson; H Rothschild
Journal:  J Natl Cancer Inst       Date:  1986-10       Impact factor: 13.506

7.  Tobacco money lights up a debate.

Authors:  J Cohen
Journal:  Science       Date:  1996-04-26       Impact factor: 47.728

8.  Changing Tobacco Control's policy on tobacco industry-funded research.

Authors:  Ruth E Malone
Journal:  Tob Control       Date:  2013-01       Impact factor: 7.552

9.  'To prove this is the industry's best hope': big tobacco's support of research on the genetics of nicotine addiction.

Authors:  Kenneth R Gundle; Molly J Dingel; Barbara A Koenig
Journal:  Addiction       Date:  2010-06       Impact factor: 6.526

10.  Tobacco industry sociological programs to influence public beliefs about smoking.

Authors:  Anne Landman; Daniel K Cortese; Stanton Glantz
Journal:  Soc Sci Med       Date:  2008-02       Impact factor: 4.634

View more
  2 in total

1.  Models of biobanks and implications for reproductive health innovation.

Authors:  Benjamin Capps
Journal:  Monash Bioeth Rev       Date:  2015-12

Review 2.  Can a good tree bring forth evil fruit? The funding of medical research by industry.

Authors:  Benjamin Capps
Journal:  Br Med Bull       Date:  2016-05-05       Impact factor: 4.291

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.